Blood sugar level regulation

Blood sugar level regulation, also known as glucose homeostasis, is a complex physiological process rather than a single molecular target. It involves the precise maintenance of blood glucose concentrations through the coordinated actions of the pancreas, liver, skeletal muscle, and adipose tissue (NIH, 2023). The primary hormonal drivers are insulin, which lowers blood glucose by facilitating cellular uptake, and glucagon, which raises blood glucose by stimulating hepatic output. Chronic disruption of this regulatory system leads to diabetes mellitus, a condition characterized by hyperglycemia and long-term microvascular and macrovascular complications. In a therapeutic context, drugs do not target 'blood sugar regulation' as a whole but instead target specific proteins within the pathway, such as the Insulin receptor, Glucagon-like peptide 1 receptor (GLP-1R), or Sodium-glucose cotransporter 2 (SGLT2) (PubMed, 2022). Therefore, this term is considered a biological process or therapeutic area rather than a specific druggable target.

Other names

Glucose homeostasisGlycemic controlBlood glucose regulationCarbohydrate homeostasis

Regulation is achieved through a coordinated hormonal feedback loop where insulin promotes glucose uptake and storage (glycogenesis) to lower blood levels, while glucagon stimulates glucose release (glycogenolysis and gluconeogenesis) to increase blood levels. Pharmacological agents target specific components of this process, such as increasing insulin sensitivity, inhibiting glucose absorption, or stimulating incretin signaling (StatPearls, 2023).